Prostate health, without the confusion.
A starting point for understanding prostate changes, screening decisions, cancer diagnosis, treatment options, and questions to discuss with healthcare professionals.
The information you need, when you need it.
Too much medical information can be as confusing as too little. These six focused guides connect tests, results, decisions, and next steps without assuming every man has the same biology or circumstances.
When PSA is rising
What the number can mean, when to repeat testing, and how to plan the next step.
Read the guideTests that clarify the picture
MRI, biopsy, Grade Groups, genomic scores and why results can disagree.
Read the guideActive surveillance
What real surveillance involves and when changing findings deserve review.
Read the guideChoosing a treatment
Compare surgery, radiation, surveillance, side effects and second opinions.
Read the guideRecovery and life afterward
Continence, sexual health, follow-up PSA and the practical recovery plan.
Read the guideInsurance and access
Prior authorization, appeal steps and preventing administrative delays.
Read the guideIndependent educational writing. No individual clinical history or patient case is presented. Guides were checked against established public sources; they have not been clinically peer reviewed.
Start with what the prostate does.
The prostate is a gland below the bladder that surrounds part of the urethra. Prostate concerns are not all the same: benign prostatic hyperplasia (BPH) is noncancerous enlargement, prostatitis involves inflammation, and prostate cancer is a distinct condition.
Understanding these differences helps frame discussions about symptoms, examinations, and possible next steps. Symptoms alone cannot tell you whether cancer is present.
Understand the test and its limits.
The prostate-specific antigen (PSA) blood test can be used in conversations about screening and follow-up. PSA can be elevated for reasons other than cancer, including benign enlargement or inflammation.
Prostate cancer screening involves potential benefits and harms. Personal risk factors, medical history, and preferences all belong in a shared discussion with a healthcare professional. There is no single decision that is right for everyone.
When results are unexpected, the important question is what happens next. Our rising PSA guide explains repeat testing, prostate size, risk assessment, and why a plan should specify the next step rather than default to either panic or complacency.
From an unexpected result to a clearer picture.
When a result needs further evaluation, healthcare teams may discuss repeat PSA testing, imaging, additional tests, or biopsy, depending on the circumstances. If cancer is diagnosed, its grade and stage help inform discussions about its likely behavior and treatment options.
The detailed testing guide explains MRI, PI-RADS, targeted and systematic biopsy, Gleason score, Grade Groups, and why additional genomic results may not always agree.
Treatment is a decision, not a single path.
Depending on the characteristics of a cancer and the person's health and priorities, care approaches may include active surveillance, surgery, radiation therapy, hormone therapy, and other treatments. The appropriate choices and potential tradeoffs vary considerably by situation.
Understand active surveillance as a documented monitoring plan, then compare treatments and their tradeoffs, including the value of meeting both surgical and radiation specialists when appropriate.
Quality of life belongs in the conversation.
Health discussions are not limited to test results and treatment decisions. Urinary, bowel, and sexual function, emotional well-being, follow-up care, and personal priorities can all matter.
The recovery and follow-up guide addresses preparation, continence, sexual health, post-treatment PSA testing, and the questions that make a care plan clearer.
Administrative access matters too. Learn how to navigate prior authorization and appeals if a recommended test is delayed.
Follow evidence, not hype.
Medical research continues to evolve. We intend to distinguish early scientific findings from evidence that has influenced clinical recommendations or regulatory decisions. Detailed update articles will be added after editorial review rather than automatically published.
Start with trusted medical sources.
The resources below provide established patient-oriented information. Linking to these organizations does not imply that they review or endorse this website.
Prostate education library updated November 5, 2026. The six guides are independently researched educational articles, not clinician-reviewed recommendations or individualized medical advice.